High-throughput flow cytometry for drug discovery: principles, applications, and case studies
Related Experiment Video
Updated: Feb 22, 2026

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
Published on: March 10, 2017
Mei Ding1, Karin Kaspersson1, David Murray2
1Discovery Sciences, Innovative Medicines and Early Development, AstraZeneca, Pepparedsleden 1, SE-43183 Mölndal, Sweden.
Abstract:
Flow cytometry is a technology providing multiparametric analysis of single cells or other suspension particles. High-throughput (HT) flow cytometry has become an attractive screening platform for drug discovery. In this review, we highlight the recent HT flow cytometry applications, and then focus on HT flow cytometry deployment at AstraZeneca (AZ). Practical considerations for successful HT flow cytometry assay development and screening are provided based on experience from four project case studies at AZ. We provide an overview of the scientific rationale, explain why HT flow cytometry was chosen and how HT flow cytometry assays deliver new ways to support the drug discovery process.

